Muscle MRI / whole-body MRI in diagnosis and dynamic evaluation of neuro-muscular disorders
https://doi.org/10.17650/2222-8721-2014-0-2-16-26
Abstract
The use of MRI in myopathies dates back to more than 20 years. The first investigations were slow and only allowed segmental and limited studies. Whole-body MRI has emerged over the past twelve years and became a useful diagnostic tool in the etiological diagnosis of myopathies and muscular dystrophies. This study must always be confronted with clinical and whichever other paraclinical data without being able to replace them. Indications to perform such an investigation are getting better and better defined and the diagnostic efficacy has progressed with the increasing number of cases, communications, publications and discussions within multidisciplinary working groups. Its noninvasive nature, the radiation-free exposure and its reasonable cost also enable this technique to be easily accepted by the patient. It also provides a valuable tool for monitoring the natural disease progression or the effectiveness of therapies. The radiology team must be acquainted with the management of neuromuscular patients. Interpreting muscle whole-body MRI requires an excellent knowledge of muscle anatomy whichever body part is examined. The radiologist performing these studies is ideally a specialist of musculoskeletal disorders or a neuroradiologist well trained in muscle anatomy.
About the Author
Robert Carlier
Imagerie Medicale, Hopital Raymond Poincare, Garches
Russian Federation
Russian Federation
References
1. Ron E. Cancer risks from medical radiation. Health Phys 2003;85(1):47–59.
2. Takamatsu N., Mori A., Nodera H. Sonographic evaluation of myopathy. Brain Nerve 2014;66(3):247–57.
3. Udd B., Lamminen A., Somer H. Imaging methods reveal unexpected patchy lesions in late onset distal myopathy. Neuromuscul Disord 1991;1(4):279–85.
4. Schedel H., Reimers C.D., Nägele M. et al. Imaging techniques in myotonic dystrophy. A comparative study of ultrasound, computed tomography and magnetic resonance imaging of skeletal muscles. Eur J Radiol 1992;15(3):230–8.
5. Lamminen A.E., Hekali P.E., Tiula E. et al. Acute rhabdomyolysis: evaluation with magnetic resonance imaging compared with computed tomography and ultrasonography. Br J Radiol 1989;62(736):326–30.
6. Lamminen A.E. Magnetic resonance imaging of primary skeletal muscle diseases patterns of distribution and severity of involvement. Br J Radiol 1990;63(756): 946–50.
7. Messineo D., Cremona A., Trinci M. et al. MRI in the study of distal primary myopathopies and of muscular alterations due to peripheral neuropathies: possible diagnostic capacities of MR equipment with low intensity field (0.2 T) dedicated to peripheral limbs. Magn Reson Imaging 1998;16(7):731–41.
8. Mercuri E., Pichiecchio A., Counsell S. et al. A short protocol for muscle MRI in children with muscular dystrophies. Eur J Paediatr Neurol 2002;6(6):305–7.
9. Mercuri E., Cini C., Counsell S. et al. Muscle MRI findings in a three-generation family affected by Bethlem myopathy. Eur J Paediatr Neurol 2002;6(6):309–14.
10. Mercuri E., Talim B., Moghadaszadeh B. et al. Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid pine syndrome linked to chromosome 1p (RSMD1). Neuromuscul Disord 2002;12 (7–8):631–8.
11. Jungbluth H., Sewry C.A., Buj-Bello A. et al. Early and severe presentation of X-linked myotubular myopathy in a girl with skewed Xinactivation. Neuromuscul Disord 2003;13(1):55–9.
12. Mercuri E., Cini C., Pichiecchio A. et al. Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul Disord 2003;13(7–8):554–8.
13. Mercuri E., Jungbluth H., Muntoni F. et al. Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 2005;18(5):526–37.
14. Lovitt S., Marden F.A., Gundogdu B. et al. MRI in myopathy. Neurol Clin 2004;22(3):509–38.
15. Ozsarlak O., Parizel P.M., De Schepper A.M. et al. Whole-body MR screening of muscles in the evaluation of neuromuscular diseases. Eur Radiol 2004;14(8):1489–93.
16. Walker R., Kessar P., Blanchard R. et al. Turbo STIR magnetic resonance imaging asa whole-body screening tool for metastases in patients with breast carcinoma: preliminaryclinical experience. J Magn Reson Imaging 2000;11(4):343–50.
17. Lauenstein T.C., Freudenberg L.S., Goehde S.C. et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 2002;12(8):2091–9.
18. Schlemmer H.P., Schäfer J., Pfannenberg C. et al. Fast whole-body assessment of metastaticdisease using a novel magnetic resonance imaging system: initial experiences. Invest Radiol 2005;40(2):64–71.
19. Goehde S.C., Hunold P., Vogt F.M. et al. Full-body cardiovascular and tumor MRI forearly detection of disease: feasibility and initial experience in 298 subjects. Am J Roentgenol 2005;184(2):598–611.
20. Engelhard K., Hollenbach H.P., Wohlfart K. et al. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol 2004;14(1):99–105.
21. Carlier R.Y., Laforet P., Wary C. et al. hole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns. Neuromuscul Disord 2011;21(11):791–9.
22. Quijano-Roy S., Carlier R.Y., Fischer D. et al. Muscle imaging in congenital myopathies. Semin Pediatr Neurol 2011;18(4):221–9.
23. Quijano-Roy S., Avila-Smirnow D., Carlier R.Y. et al. Whole body muscle MRI protocol: pattern recognition in early onset NM disorders. Neuromuscul Disord 2012; 22 Suppl 2:68–84.
24. Jarraya M., Quijano-Roy S., Monnier N. et al. Whole-Body muscle MRI in a series of atients with congenital myopathy related to TPM2 gene mutations. Neuromuscul Disord 2012;22 Suppl 2:137–47.
25. Sarkozy A., Deschauer M., Carlier R.Y. et al. Muscle MRI findings in limb girdle muscular dystrophy type 2L. Neuromuscul Disord 2012;22 Suppl 2:122–9.
26. Mercuri E., Manzur A., Main M. et al. Is there post-natal muscle growth in amyoplasia? A sequential MRI study. Neuromuscul Disord 2009;19(6):444–5.
27. Goutallier D., Postel J.M., Bernageau J. et al. Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan. Clin Orthop Relat Res 1994;(304): 78–83.
28. Mercuri E., Pichiecchio A., Allsop J. et al. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 2007;25(2):433–40.
29. Dieterich K., Quijano-Roy S., Monnier N. et al. The neuronal endopeptidase ECEL1 is associated with a distinct form of recessive distal arthrogryposis. Hum Mol Genet 2013;22(8):1483–92.
30. Ohana M., Moser T., Moussaouï A. et al. Current and future imaging of the peripheral nervous system. Diagn Interv Imaging 2014;95(1):17–26.
31. Wattjes M.P., Kley R.A., Fischer D. Neuromuscular imaging in inherited muscle diseases. Eur Radiol 2010;20(10):2447–60.
32. Schramm N., Born C., Weckbach S. et al. Involvement patterns in myotilinopathy and desminopathy detected by a novel neuromuscular whole-body MRI protocol. Eur Radiol 2008;18(12):2922–36.
33. Kesper K., Kornblum C., Reimann J. et al. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study. Acta Neurol Scand 2009;120(2):111–8.
34. Straub V., Carlier P.G., Mercuri E. TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI: 25–26 February 2011, Rome, Italy. Neuromuscul Disord 2012;22 Suppl 2: 42–53.
Review
For citations:
Carlier R. Muscle MRI / whole-body MRI in diagnosis and dynamic evaluation of neuro-muscular disorders. Neuromuscular Diseases. 2014;(2):16-26. (In Russ.) https://doi.org/10.17650/2222-8721-2014-0-2-16-26
Views: 1104
Email this article 